AI Science Tracker
EN

Department of Nephrology, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.

1 discovery from 2024

Discoveries

Innovative label-free lymphoma diagnosis using infrared spectroscopy and machine learning on tissue sections.

Source check: Source checked. Not independent scientific confirmation.

Finding: PLS-DA on infrared tissue spectra distinguished lymphoma from non-malignant lymphoid tissue on an independent test set (AUC 0.882). AI role: Partial least-squares discriminant analysis (PLS-DA) on ATR-FTIR spectra. The article appeared in Communications Biology.

Technology: Partial least-squares discriminant analysis (PLS-DA) on ATR-FTIR spectra

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Partial least-squares discriminant analysis (PLS-DA) on ATR-FTIR spectra
Test and result
PLS-DA on infrared tissue spectra distinguished lymphoma from non-malignant lymphoid tissue on an independent test set (AUC 0.882).
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s42003-024-07111-7 · https://pubmed.ncbi.nlm.nih.gov/39482420/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.